Diisopropylethylamine → [4-(3,6-Dimethyl-4,10-dihydro-3H-2,3,4,9-tetraaza-benzo[f]azulene-9-carbonyl)-2-fluoro-benzyl]-carbamic Acid Tert-butyl Ester
反応式
[C:1]([O:5][C:6]([NH:8][CH2:9][C:10]1[CH:18]=[CH:17][C:13]([C:14]([OH:16])=O)=[CH:12][C:11]=1[F:19])=[O:7])([CH3:4])([CH3:3])[CH3:2].CCN(C(C)C)C(C)C.[CH3:29][N:30]1[C:39]2[NH:38][C:37]3[CH:40]=[C:41]([CH3:44])[CH:42]=[CH:43][C:36]=3[NH:35][CH2:34][C:33]=2[CH:32]=[N:31]1>CN(C1C=CN=CC=1)C.ClCCl>[C:1]([O:5][C:6](=[O:7])[NH:8][CH2:9][C:10]1[CH:18]=[CH:17][C:13]([C:14]([N:35]2[CH2:34][C:33]3[CH:32]=[N:31][N:30]([CH3:29])[C:39]=3[NH:38][C:37]3[CH:40]=[C:41]([CH3:44])[CH:42]=[CH:43][C:36]2=3)=[O:16])=[CH:12][C:11]=1[F:19])([CH3:2])([CH3:3])[CH3:4]参加物
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
A solution of 4-(tert-butoxycarbonylamino-methyl)-3-fluorobenzoic acid from Example E3.1 (538 mg, 2.0 mmol) and DMAP (220 mg, 1.8 mmol) in dichloromethane (20 ml) at room temperature was treated with DIEA (0.93 ml, 5.4 mmol) and WSCD (460 mg, 2.4 mmol), and the resulting solution was stirred at room temperature for 1 h. 3,6-Dimethyl-3,4,9,10-tetrahydro-2,3,4,9-tetraaza-benzo[f]azulene from Example E2 (385 mg, 1.8 mmol) was added and the resulting solution was heated at reflux for 20 h and allowed to cool to room temperature. The solution was diluted with dichloromethane, washed with saturated NaHCO3 and brine and concentrated in vacuo. The residue was purified by preparative HPLC (eluant 10% methanol:90% dichloromethane) to yield the title compound (265 mg, 32%).
後処理
- customat room temperature
- temperaturethe resulting solution was heated
- temperatureat reflux for 20 h
- temperatureto cool to room temperature
- washwashed with saturated NaHCO3 and brine
- concentrationconcentrated in vacuo
- customThe residue was purified by preparative HPLC (eluant 10% methanol:90% dichloromethane)
出典と根拠
- ORDレコード
- ord-0ee1672c8ea043fd9d2e8f09f60e17e5
- 出典データセット
- uspto-grants-2012_06
- 特許番号
- US08202858B2
反応ノート
読み込み中…